Latest publication, first author
MDM4 at the Crossroads: Beyond p53 and MDM2
Thapa D, St John A, et al. Cancers. 2026;18(7):1059. Review article.
Read the paperCancer biology PhD candidate at the University of Kansas Medical Center, studying how p53 is kept in check.
Toggle stains in this illustration
p53 is often called the guardian of the genome. When a cell is damaged, p53 can pause its growth or trigger its death, which stops it from becoming cancerous. Many tumors find ways to switch p53 off.
Two proteins, MDM2 and MDM4, keep p53 under control. My doctoral work focuses on MDM4, and on the roles it plays in cancer beyond its partnership with p53 and MDM2.
Alongside my PhD, I am a research learner in Graduate Medical Education at Children's Mercy Kansas City.
Tap a protein to see its role
A tumor suppressor protein. When DNA is damaged, p53 can halt cell division or trigger cell death. It also switches on the gene for MDM2, which creates a feedback loop.
Latest publication, first author
MDM4 at the Crossroads: Beyond p53 and MDM2
Thapa D, St John A, et al. Cancers. 2026;18(7):1059. Review article.
Read the paperUniversity of Kansas Medical Center, Kansas City, KS
Research on the tumor suppressor p53 and its regulators.
Children's Mercy Kansas City, Kansas City, MO
Laboratory research using western blotting, X-ray irradiation of biological samples, and micro-CT imaging.
Washburn University, Topeka, KS
Mutated wild-type lactate dehydrogenase (LDH) to study structural changes in the enzyme using circular dichroism.
Washburn University, Topeka, KS
Prepared chemicals and organized equipment for the biochemistry teaching lab.
American Association for Cancer Research
Awarded on the quality of my abstract to support attendance at the AACR Annual Meeting 2025 in Chicago. Funded by Sanofi to recognize outstanding young investigators in cancer research.
Department of Cancer Biology, University of Kansas Medical Center
Supports travel to present research at scientific conferences.
K-INBRE (Kansas IDeA Network of Biomedical Research Excellence), Washburn University
K-INBRE is supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the NIH.
Department of Chemistry, Washburn University
Awarded for outstanding academic performance, renewed for three consecutive academic years.
Washburn University
Kansas Academy of Science
University of Kansas Medical Center
Aug 2022 to Aug 2027 (expected)
Washburn University
Aug 2018 to May 2022
American Association for Cancer Research, associate member since Sep 2024
Phi Kappa Phi Honor Society, Nov 2021 to Aug 2022
Nepali (native), English and Hindi (full professional)
Communicating with Confidence, Jeff Ansell & Associates, Mar 2022